Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-23T19:23:07.207Z Has data issue: false hasContentIssue false
  • English
  • Français

Voice outcomes following transoral laser microsurgery for early glottic squamous cell carcinoma

Published online by Cambridge University Press:  20 April 2007

J T Kennedy ,
P M Paddle ,
B J Cook ,
P Chapman  and
T A Iseli
J T Kennedy
Affiliation:
Department of Otolaryngology, Head and Neck SurgerySt Vincent's Hospital, Victoria, Australia.
P M Paddle
Affiliation:
Department of Otolaryngology, Head and Neck SurgerySt Vincent's Hospital, Victoria, Australia.
B J Cook
Affiliation:
Department of Otolaryngology, Head and Neck SurgerySt Vincent's Hospital, Victoria, Australia.
P Chapman
Affiliation:
Department of Speech Pathology, St Vincent's Hospital, Victoria, Australia
T A Iseli*
Affiliation:
Department of Otolaryngology, Head and Neck SurgerySt Vincent's Hospital, Victoria, Australia.
*
Address for correspondence: Mr Tim Iseli, Suite 90, level 9, 166 Gipps St, East Melbourne VIC 3002, Australia. Fax: 613 9288 4650 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Early glottic cancer may be treated with primary radiotherapy or transoral laser microsurgery with comparable survival. The choice of therapy therefore depends on patient preference after discussion of risks, benefits and alternatives.

Materials and methods:

All previously untreated patients undergoing transoral laser microsurgery for T1 or T2 glottic cancer at St Vincent's Hospital between July 1997 and December 2004 had their staging and demographics recorded. Surgery was categorised according to the European Laryngological Society. A voice recording was made pre-operatively then at 12 weeks post-operatively and scored by two independent speech therapists on the Oates Russell Voice Profile – a scale of zero (normal) to five (severe dysphonia). Follow up was for a minimum of two years.

Results and analysis:

Fifty-three patients with a mean age of 56 were included. The observed survival was T1 89.4 per cent and T2 85.3 per cent after a mean follow up of 47 months. Nineteen patients staged T1 underwent cordectomy. A second procedure was required in 22.2 per cent, however, none required a laryngectomy. Thirty-four patients staged T2 underwent hemilaryngectomy. A second procedure was required in 41.2 per cent including 8.8 per cent requiring salvage laryngectomy. One patient died with unresectable nodal disease. The mean Oates Russell Voice Profile for T1 disease was 2.37 and for T2 2.68 (range 1 to 4) indicating a mild (2) to moderate (3) degree of voice impairment.

Conclusions:

Survival outcomes following transoral laser microsurgery are comparable to treatment with radiotherapy. Voice impairment is usually mild to moderate following transoral laser microsurgery for early glottic cancer but overall may be greater than in radiotherapy patients. The repeatability of transoral laser microsurgery may result in a lower laryngectomy rate compared with published series using radiotherapy.

Keywords

Laser SurgeryLarynx NeoplasmsVoice
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 121 , Issue 12 , December 2007 , pp. 1184 - 1188
Copyright
Copyright © JLO (1984) Limited 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 AIHW & AACR. Cancer in Australia 2001. Canberra: AIHW & AACR, 2004;78–9 available at: http://www.aihw.gov.au/publications/can/ca01/ca01-c03.pdf [20 February 2006]Google Scholar
2 Hoffman, HT, Karnell, LH. Laryngeal cancer. In: Steele, GD, Jessup, JM, Winchester, DP, Menck, HR, Murphy, GP, eds. National Cancer Database Annual Review of Patient Care, 1995. Atlanta: American Cancer Society, 1995;84–100Google Scholar
3 Dey, P, Arnold, D, Wight, R, MacKenzie, K, Kelly, C, Wilson, J. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev 2003;2: CD002027. DOI: 10.1002/14651858.CD002027Google Scholar
4 Strong, MS, Jako, GJ. Laser surgery in the larynx: early clinical experience with continuous CO2 laser. Ann Otol Rhinol Laryngol 1972;1:791–3CrossRefGoogle Scholar
5 Steiner, W. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol 1993;14:116–21Google Scholar
6 Shah, JP, Karnell, LH, Hoffman, HT, Ariyan, S, Brown, G, Fee, E et al. Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg 1997;123:475–83Google Scholar
7 Parson, JT, Greene, BD, Speer, TW, Kirkpatrick, SA, Barhorst, DB, Yanckowitz, T. Treatment of early and moderately advanced vocal cord carcinoma with 6 MV X-rays. J Radiat Oncol Biol Phys 2001;50:953–9CrossRefGoogle Scholar
8 Remacle, M, Eckel, HE, Antonelli, A, Brasnu, D, Chevalier, D, Friedrich, G et al. . Endoscopic cordectomy: a proposal for a classification by the Working Committee, European Laryngological Society. Eur Arch Otorhinolaryngol 2000;257:227–31Google Scholar
9 Oates, J, Russell, A. Learning voice analysis using an interactive multi-media package: development and preliminary evaluation. J Voice 1998;12:500–12CrossRefGoogle ScholarPubMed
10 Cragle, S, Brandenburg, J. Laser cordectomy or radiotherapy: cure rates, communication and cost. Otolaryngol Head Neck Surg 1993;108:648–51CrossRefGoogle ScholarPubMed
11 Casiano, RR, Cooper, JD, Lundy, DS, Chandler, JR. Laser cordectomy for T1 glottic cancer: a 10-year experience and videostroboscopic findings. Otolaryngol Head Neck Surg 1991;104:831–5Google Scholar
12 Epstein, BE, Lee, DJ, Kashima, H, Johns, ME. Stage T1 glottic carcinoma: results of radiation therapy or laser excision. Radiology 1992;101:49–54Google Scholar
13 Hoyt, DJ, Lettinga, JW, Leopold, KA, Fisher, SR. The effect of head and neck radiation therapy on voice quality. Laryngoscope 1992;102:477–80CrossRefGoogle ScholarPubMed
14 Rydell, R, Schalen, L, Fex, S, Elner, A. Voice evaluation before and after laser excision vs. radiotherapy of T1A glottic carcinoma. Acta Otolaryngol (Stockh) 1995;115:560–5CrossRefGoogle ScholarPubMed
15 Schuller, DE, Trudeau, M, Bistline, J, LaFace, K. Evaluation of voice by patients and close relatives following different laryngeal cancer treatments. J Surg Oncol 1990;44:10–14CrossRefGoogle ScholarPubMed
16 Ton-Van, J, Stern, JC, Buisset, E, Coche-Dequeant, B, Vankemmel, B. Comparison of surgery and radiotherapy in T1 and T2 glottic carcinomas. Am J Surg 1991;162:337–40CrossRefGoogle ScholarPubMed
17 Howell-Burke, D, Peters, LJ, Goepfert, H, Oswald, MJ. T2 glottic cancer: recurrence, salvage, and survival after definitive radiotherapy. Arch Otolaryngol Head Neck Surg 1990;116:830–5CrossRefGoogle ScholarPubMed
18 DeSanto, LW. Early supraglottic cancer. Ann Otol Rhinol Laryngol 1990;99:593–8Google Scholar
19 Morris, MR, Canonico, D, Blank, C. A critical review of radiotherapy in the management of T1 glottic carcinoma. Am J Otolaryngol 1994;15:276–34Google Scholar
20 Jorgensen, K, Godballe, C, Hansen, O. Cancer of the larynx treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients. Acta Oncologica 2002;41:69–76Google Scholar
21 Chevalier, D, Laccourreye, O, Brasnu, D, Laccourreye, H, Piquet, JJ. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncology results with 112 patients. Ann Otol Rhinol Laryngol 1997;106:364–9CrossRefGoogle ScholarPubMed
22 Shah, JP, Loree, TR, Kowalski, L. Conservation surgery for radiation failure in carcinoma of the glottic larynx. Clin Otolaryngol 1994;19:105–8Google Scholar
23 Eckel, HE. Local recurrence following transoral laser surgery for early glottic carcinoma: frequency, management and outcome. Ann Otol Rhinol Laryngol 2001;110:7–15Google Scholar
24 Steiner, W, Vogt, P, Ambrosch, P, Kron, M. Transoral carbon dioxide laser microsurgery for recurrent glottic carcinoma after radiotherapy. Head & Neck 2004;26:477–84Google Scholar